Publication | Closed Access

Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts

Hematological MalignancyQuantitative Rt-pcr AmplificationOncologyFusion TranscriptsMedicineMixed-phenotype Acute LeukemiaHematologyMyeloid NeoplasiaPathologyAdult T-cell Leukemia-lymphomaMolecular DiagnosticsRadiation OncologyCancer ResearchMinimal Residual DiseaseHealth Sciences